IL-18-knockout (Il18−/−) mice also showed dyslipidemia, non-alcoholic fatty liver disease (NAFLD), or non-alcoholic steatohepatitis (NASH) [3]. Here, IL18 is linked to metabolic dysfunction-associated steatotic liver disease.